Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by francois21on Oct 12, 2016 6:04pm
538 Views
Post# 25337083

RE:I think we open at 3.22 tomorrow. !

RE:I think we open at 3.22 tomorrow. !The raise of the SP is fun. 

But on the long term, for me the results are more important. 

People may stick on the fact that this is only for 5 patients, however, for 5 five patients, not only they stop the progression of the fibrosis, but it's even better as it's reduce it after 12 weeks.

You just can't trick liver blood enzyme results or a fibroscan result with a placebo effect. 

I can't wait to have more meat on the analyst day with more data, but we have a serious proof of concept here.

I'm not as conservative like analysts are, but these results for are a large "de-risk" for the potential of PBI-4050.   
Bullboard Posts